Our Story

 

 

WE’RE AN EVENT THAT’S CHANGING
THE VACCINE INDUSTRY

 

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year. 


Now in it’s 21st year the World Vaccine Congress Europe and co-located events, Veterinary Vaccine and Immuno-Oncology congresses will continue to bring experts from the whole value chain under one roof.

With 800+ potential customers in attendance there will be opportunities to find contacts who need to find solutions to challenges around the political, commercial and scientific issues in manufacturing, clinical trials, strategy, regulation, veterinary vaccines, immune profiling, AMR, respiratory, influenza, therapeutic and emerging diseases.
 

This one event will provide you with a one stop progressive scientific and strategic solution to the vaccine and biologics industry. We bring about faster, more cost effective and more efficacious vaccines, through executive level commentary, case studies and real time analysis from key stakeholders. 


Influenza & Respiratory Emerging & Re-emerging Clinical Trials Bioprocessing & Manufacturing Technology Antimicrobial Ressistance Immunology Oncology Vaccines Clinical Development

 

 

 

 

EVENT FORMAT

Hundreds of Speakers
Start-Up Zone
World Leading Keynotes
Partnering Meeting System
10 streams of content
Exhibition Showcase
Interactive Roundtables
Peer to peer Networking
Evening Drinks Receptions
800+ Attendees
3 congresses, one event

 

 

CO-LOCATED WITH

 

 

CONFERENCE TRACKS

 

 

 

FROM STRENGTH TO STRENGTH

The World Vaccine Congress Europe has gone from strength to strength and has experienced fantastic growth. 2020 will be an unmissable edition where 800+ industry professionals will join us in Barcelona.

 

From 2018-2019

EXHIBITING
companies up
300%
DELEGATE
numbers up
225%
121 PARTNERING
meetings up
250%
SPEAKER
numbers up
175%

 

WHY NOW?

DISEASE X

Threatened by infectious diseases and the unknown, it’s more important than ever to unite every stakeholder from policy makers in government, HTA/payers, healthcare professionals, academic scientists to manufacturers and new SMEs to challenge the existing vaccine lifecycle model, at the biggest and most established European vaccine meeting.

ONE HEALTH

It is imperative for synergy between human and animal health to combat emerging zoonotic & transboundary diseases. The One Health holistic approach helps accelerate research & development and collaboration between human and animal health in key areas such as; Innovation, Zoonotic & Transboundary Diseases, Technology Platforms, Vaccines, Clinical Models, Adjuvants & Immunotherapy.

IMMUNO-ONCOLOGY

There is significant crossover between infectious disease and cancer when it comes to immune characterisation, interplay with T/B cells, multifaceted technology platforms, vaccine & antibody design. Join us as we discuss the importance of a united approach to advance infectious disease & cancer treatment. Regardless of whether your concerns are with the aging population, the young or the neglected, we cover such a broad scope of topics and diseases at such depth, that you’ll leave satisfied that you spent an incredibly productive few days with us.

 

CATALONIA IS A GREAT PLACE FOR INTERNATIONAL PHARMACEUTICAL COMPANIES

 

  • 2017 saw 125 Pharma companies in Catalonia
     
  • Catalonia concentrated 71.6% of Spanish pharmaceutical turnover (2017) and 43.7% of Spanish pharmaceutical exports (2016)
     
  • Catalonia is the birthplace of pharmaceuticals in Spain and home to the five biggest Spanish Pharmaceutical companies
     
  • R&D spending of Catalan pharmaceutical industry accounts for 32.1% of total Catalan industry spending in R&D